← 返回 Skills 市场
hanxueyuan

Sanofi Group

作者 hanxueyuan · GitHub ↗ · v1.0.0 · MIT-0
cross-platform ✓ 安全检测通过
55
总下载
0
收藏
0
当前安装
1
版本数
在 OpenClaw 中安装
/install sanofi-group
功能描述
Sanofi is a top-10 global pharma company leading in vaccines, rare diseases, and consumer healthcare, generating €43B+ annually with key products like Dupixent.
使用说明 (SKILL.md)

Sanofi Group

概述

Sanofi — France's largest pharmaceutical company and a top-10 global pharma player generating €43B+ annually, with leadership in vaccines, rare diseases, and consumer healthcare.

历史时间线

  • 1973: Sanofi founded by Elf Aquitaine (French oil company) as pharmaceutical division
  • 1999: Merger with Synthélabo creates Sanofi-Synthélabo
  • 2004: Acquires Aventis for €52B; becomes Sanofi-Aventis
  • 2011: Acquires Genzyme for $20B; enters rare disease market
  • 2019: Acquires Bioverativ; renames to Sanofi
  • 2020: COVID-19 vaccine development partnership with GSK (later pivots to mRNA)
  • 2023: Paul Hudson becomes CEO; announces 'Play to Win' strategy
  • 2024: €43B+ revenue; immunology and rare diseases driving growth

商业模式

Three operating segments: Pharmaceuticals (specialty care, immunology, rare diseases, ~60% of revenue), Vaccines (influenza, pediatric, travel, ~20%), and Consumer Healthcare (OTC medicines, vitamins, ~20%). Key products include Dupixent (immunology, $10B+ blockbuster), Dupilumab pipeline, and vaccine portfolio including flu and polio.

护城河分析

Vaccine manufacturing scale: Sanofi is the world's largest vaccine producer by volume, with facilities on 5 continents. Dupixent moat: the immunology drug generates $10B+ annually with 10+ years of patent protection remaining. Rare disease expertise: Genzyme acquisition gave Sanofi deep capabilities in enzyme replacement therapies. European regulatory relationships provide faster EU approvals.

关键数据

  • revenue: €43+ billion (2023)
  • employees: 90,000+ in 100+ countries
  • key_product: Dupixent ($10B+ blockbuster with Regeneron partnership)
  • r_and_d: ~€6 billion annually
  • headquarters: Paris, France

有趣事实

  • Sanofi's vaccine division produces over 2 billion doses annually — that's roughly one vaccine for every four people on Earth each year
  • The Genzyme acquisition in 2011 was controversial at the time ($20.1B for a company with one key product), but it gave Sanofi the rare disease expertise that now generates €8B+ annually
安全使用建议
This skill appears safe from an agentic security perspective. Treat it as static reference content and independently verify business facts if accuracy matters.
功能分析
Type: OpenClaw Skill Name: sanofi-group Version: 1.0.0 The skill bundle contains purely informational documentation about the Sanofi pharmaceutical group. There is no executable code, no network activity, and no evidence of prompt injection or malicious intent within SKILL.md or _meta.json.
能力评估
✓ Purpose & Capability
The artifact is coherent with its stated purpose: it provides background research content about Sanofi.
✓ Instruction Scope
The instructions are limited to when the skill should be read for research contexts and do not tell the agent to take external actions.
✓ Install Mechanism
There is no install spec, no dependencies, and no code files.
✓ Credentials
The skill declares no required binaries, environment variables, credentials, config paths, or OS-specific access.
✓ Persistence & Privilege
No persistence, background behavior, privilege use, account access, or local data access is shown.
如何使用
  1. 确保已安装 OpenClaw（本地或 Docker 部署）
  2. 在对话框中输入安装命令：/install sanofi-group
  3. 安装完成后，直接呼叫该 Skill 的名称或使用 /sanofi-group 触发
  4. 根据 Skill 的参数说明提供必要输入，即可获得结构化输出
版本历史
v1.0.0
Sanofi Group skill version 1.0.0 introduces detailed company information and strategic context. - Provides a comprehensive overview of Sanofi, including history, key figures, and market leadership. - Outlines company business segments with revenue breakdown and flagship products (e.g., Dupixent, vaccines). - Highlights Sanofi's competitive advantages in vaccine manufacturing, patents, and rare diseases. - Includes a timeline of major events and acquisitions shaping the company's growth. - Offers key data points and interesting facts for industry research or comparison.
元数据
Slug sanofi-group
版本 1.0.0
许可证 MIT-0
累计安装 0
当前安装数 0
历史版本数 1
常见问题

Sanofi Group 是什么？

Sanofi is a top-10 global pharma company leading in vaccines, rare diseases, and consumer healthcare, generating €43B+ annually with key products like Dupixent. 它是一个面向 Claude Code / OpenClaw 的 AI Agent Skill 插件，目前累计下载 55 次。

如何安装 Sanofi Group？

在 OpenClaw 或 Claude Code 对话框中运行命令「/install sanofi-group」即可一键安装，无需额外配置。

Sanofi Group 是免费的吗？

是的，Sanofi Group 完全免费，采用 MIT-0 许可证，可自由下载、安装和使用。

Sanofi Group 支持哪些平台？

Sanofi Group 跨平台运行，可在任意部署了 OpenClaw / Claude Code 的环境中使用（cross-platform）。

谁开发了 Sanofi Group？

由 hanxueyuan（@hanxueyuan）开发并维护，当前版本 v1.0.0。

推荐 Skills
self-improving agent
Captures learnings, errors, and corrections to enable continuous improvement. Use when: (1) A command or operation fails unexpectedly, (2) User corrects Clau...
⬇ 463283 · by pskoett
Skill Vetter
Security-first skill vetting for AI agents. Use before installing any skill from ClawdHub, GitHub, or other sources. Checks for red flags, permission scope, and suspicious patterns.
⬇ 259410 · by spclaudehome
Polymarket
Query Polymarket prediction markets. Check odds, find trending markets, search events, track price movements.
⬇ 232503 · by joelchance
Self-Improving + Proactive Agent
Self-reflection + Self-criticism + Self-learning + Self-organizing memory. Agent evaluates its own work, catches mistakes, and improves permanently. Use when...
⬇ 200423 · by ivangdavila
Github
Interact with GitHub using the `gh` CLI. Use `gh issue`, `gh pr`, `gh run`, and `gh api` for issues, PRs, CI runs, and advanced queries.
⬇ 191115 · by steipete
ontology
Typed knowledge graph for structured agent memory and composable skills. Use when creating/querying entities (Person, Project, Task, Event, Document), linkin...
⬇ 190156 · by oswalpalash

💬 留言讨论